Align Technology, Inc. ALGN
NASDAQ · Healthcare · Medical - Devices
$155.17
Close on Fri, 20 Nov 2026 · market value $10.9B
What the price is betting on
Priced for a lot to go rightAt $155, the price assumes revenue grows about 8.8% a year for five years, from $4.2B to about $6B by FY2030. That is about four times what analysts expect for the next two years and about three times the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 11% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than ALGN? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$111
Base
$121
Bull
$133
Today $155
- Bear $111. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $121. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $133. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$4.2B$4.1B, on the path
- FY2027$4.6B$4.2B, below the path
- FY2028$5B$4.4B, below the path
- FY2029$5.5B$4.7B, below the path
- FY2030$6BThe full bet
Each year's revenue at 8.8% growth from $4.2B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Devices · listed on NASDAQ
- Revenue, FY2025
- $4B
- Growth, 3 years a year
- 2.7%
- Cash margin
- 12%
- Net cash
- $980M
- Shares, 3-year change
- −7.4%
- Dividend yield
- 0%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.